SNSE SCHEDULE 13G: SEC filing

Avoro Capital Advisors LLC

Filed with the SEC on · accession 0000902664-26-004544

SNSE filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Avoro Capital Advisors LLC filed a Schedule 13G disclosing beneficial ownership of 1,410,000 shares (5.46%) of Faeth Therapeutics, Inc. common stock as of September 30, 2026, held for investment purposes on behalf of Avoro Life Sciences Fund LLC.

Key details

Shares of common stock beneficially owned$1.4M
Percentage of class beneficially ownedPCT 5
Reporting person / beneficial ownerAvoro Capital Advisors LLC
Fund on whose behalf shares are heldAvoro Life Sciences Fund LLC
Issuer of the securitiesFaeth Therapeutics, Inc.
Portfolio manager and controlling person of avoro capital advisors llcBehzad Aghazadeh
Chief operating officer and chief compliance officer, avoro capital advisors llcScott Epstein

✦ Ask GOAX AI about this filing — what it means for SNSE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SNSE?

Click here

Frequently asked questions

What did SNSE file with the SEC on Nov 16, 2026?

SNSE filed a SCHEDULE 13G (SEC filing). Avoro Capital Advisors LLC filed a Schedule 13G disclosing beneficial ownership of 1,410,000 shares (5.46%) of Faeth Therapeutics, Inc. common stock as of September 30, 2026, held for investment purposes on behalf of Avoro Life Sciences Fund LLC.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

Other SNSE SEC filings

Get alerts when SNSE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days